NCT06588491View on ClinicalTrials.gov

KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
Stiff-Person SyndromeSPS
Interventions
BIOLOGICAL

Standard lymphodepletion regimen

Standard lymphodepletion regimen

Trial Locations (3)

19107

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

55905

RECRUITING

Mayo Clinic, Rochester

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

Sponsors
All Listed Sponsors
lead

Kyverna Therapeutics

INDUSTRY